Related Experiment Video
Updated: Jun 20, 2025

Associated Chromosome Trap for Identifying Long-range DNA Interactions
Published on: April 23, 2011
HLA-B*51:197: A composite product of interlocus recombination of B*51:01:01:01 and C*01:02:01:01
Niels Kouprie1, Laura B Bungener1, Annechien J A Lambeck1
1Transplantation Immunology, Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Insights
The novel HLA-B*51:197 allele was discovered. It arose from the recombination of two other HLA alleles, HLA-B*51:01:01:01 and HLA-C*01:02:01:01.
Area of Science:
- Human leukocyte antigen (HLA) genetics
- Molecular evolution
- Immunogenetics
Background:
- The human leukocyte antigen (HLA) system is crucial for immune response.
- Allelic diversity within HLA genes is extensive.
- Understanding HLA allele origins is vital for transplantation and disease association studies.
Purpose of the Study:
- To characterize the origin of the novel HLA-B*51:197 allele.
- To investigate the mechanism of its formation.
Main Methods:
- Sequence analysis of HLA-B and HLA-C genes.
- Comparative genomics to identify recombination events.
Main Results:
- The HLA-B*51:197 allele was identified.
- Sequence analysis confirmed it originated from interlocus recombination.
- The recombination event involved HLA-B*51:01:01:01 and HLA-C*01:02:01:01.
Conclusions:
- Interlocus recombination is a significant mechanism for generating novel HLA alleles.
- This finding expands the known allelic repertoire of the HLA-B locus.
- The discovery of HLA-B*51:197 provides new insights into HLA evolution.
Abstract:
The HLA-B*51:197 allele is generated from the interlocus recombination of both HLA-B*51:01:01:01 and HLA-C*01:02:01:01 alleles.
More Related Videos
09:40Quantitation and Analysis of the Formation of HO-Endonuclease Stimulated Chromosomal Translocations by Single-Strand Annealing in Saccharomyces cerevisiae
Published on: September 23, 2011
11:17Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021